Standout Papers
Citation Impact
Citing Papers
Multidimensional traction force microscopy reveals out-of-plane rotational moments about focal adhesions
2012 StandoutNobel
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
2008
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
2008
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Vitamin D Insufficiency: Disease or No Disease?
2008
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
2009
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.
1998
Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain.
1988
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta
2012
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
2010
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review
2013
A systematic review of hip fracture incidence and probability of fracture worldwide
2012
Characterization of the Structural Features and Interactions of Sclerostin
2009
UK clinical guideline for the prevention and treatment of osteoporosis
2017
Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.
1989
Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity
2016
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
2003
The complexities of skeletal biology
2003 StandoutNature
The −9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPα and FOXA1 binding is associated with osteoporosis
2009
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Genetic Factors in Bone Turnover*
1991
Osteoporosis
2006
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Bone Formation Rate in Older Normal Women: Concurrent Assessment with Bone Histomorphometry, Calcium Kinetics, and Biochemical Markers*
1988
Effects of a Low Saturated Fat, Low Cholesterol Fish Oil Supplement in Hypertriglyceridemic Patients
1988
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Can the Hypotriglyceridemic Effect of Fish Oil Concentrate Be Sustained?
1989
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
Multiple Genetic Loci for Bone Mineral Density and Fractures
2008
Emerging therapeutic opportunities for skeletal restoration
2011
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
2007
Bisphosphonate Treatment Suppresses Not Only Stochastic Remodeling but Also the Targeted Repair of Microdamage
2001
Intrinsic Material Properties of Trabecular Bone by Nanoindentation Testing of Biopsies Taken from Healthy Women Before and After Menopause
2012
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effects of DeflazacortVersusPrednisone on Bone Mass, Body Composition, and Lipid Profile: A Randomized, Double Blind Study in Kidney Transplant Patients1
1998
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures
2012
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
2008
Evaluation of a threshold-based tri-axial accelerometer fall detection algorithm
2006
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
1997 StandoutNature
DIETARY CALCIUM AND RISK OF HIP FRACTURE: 14-YEAR PROSPECTIVE POPULATION STUDY
1988
Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients
1991
Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis
2015
Vitamin D Deficiency
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
High Dietary Protein Intake and Protein-Related Acid Load on Bone Health
2017
Circulating Sclerostin in Disorders of Parathyroid Gland Function
2011
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
1998
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
2011
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
2008
Does osteocytic SOST suppression mediate PTH bone anabolism?
2010
Targeted Regeneration of Bone in the Osteoporotic Human Femur
2011
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Osteoporosis: now and the future
2011 Standout
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
2014 Standout
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Parathyroid Hormone as an Anabolic Skeletal Therapy
2005
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
1999
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
2009
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
2011
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Prevention of Estrogen Deficiency–Related Bone Loss With Human Parathyroid Hormone–(1-34)
1998
New sequence variants associated with bone mineral density
2008
Three-dimensional reconstruction of chick calvarial osteocytes and their cell processes using confocal microscopy
2005 StandoutNobel
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Long‐term ovariectomy decreases ovine compact bone viscoelasticity
2005
Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration
1999
Imminent risk of fracture after fracture
2016
PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis
1996
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats
2000
A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men
2016
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
1995
NMR structure of the Wnt modulator protein Sclerostin
2009
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid‐treated mice
2008
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Geographic trends in incidence of hip fractures: a comprehensive literature review
2011
Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects
1988
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
1998
Anthropometric Indicators and Hip Fracture
1989
Effect of four monthly oral vitamin D 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
2003
Using Osteoporosis Therapies in Combination
2017
Osteoclast differentiation and activation
2003 StandoutNature
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
2014
Epidemiology of Vertebral Fractures
2015
Triglyceride lowering effect of MaxEPA fish lipid concentrate: A multicentre placebo controlled double blind study
1988
Assessment of fracture risk
2004
Cancer immunotherapy comes of age
2011 StandoutNature
Is Cortical Bone Hip? What determines Cortical Bone Properties?
2007
The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
2008
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 1: Hip Geometry
2015
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass
2005
Inhibition of atherosclerosis by fish oil in cholesterol-fed rabbits
1988
Falls in advanced old age: recalled falls and prospective follow-up of over-90-year-olds in the Cambridge City over-75s Cohort study
2008
Femoral strength in osteoporotic women treated with teriparatide or alendronate
2011
Anabolic Actions of Parathyroid Hormone on Bone*
1993
Emerging therapeutic concepts for muscle and bone preservation/building
2015
Increased risk of hip fracture among patients with end-stage renal disease
2000
Prevalence of Hypovitaminosis D in Cardiovascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004)
2008
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
2007
The Assessment of Fracture Risk
2010
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease
1994
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
1990
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Biochemical Markers of Bone Metabolism: An Overview
1997
Low bone mineral density and fracture burden in postmenopausal women
2007
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
2009
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
2010
Hip Axis Length Is a FRAX- and Bone Density-Independent Risk Factor for Hip Fracture in Women
2015
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
2010
Medication Use Patterns for Osteoporosis: An Assessment of Guidelines, Treatment Rates, and Quality Improvement Interventions
2005
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
2016
Trabecular Bone Score
2016
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Fibroblast biology in three-dimensional collagen matrices
2003
Determination of Dual Effects of Parathyroid Hormone on Skeletal Gene Expression in Vivo by Microarray and Network Analysis
2007
Guanine nucleotide binding-protein coupled signaling pathway regulation of osteoblast-mediated bone formation
1996
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
Sonochemical synthesis of amorphous iron
1991 StandoutNature
Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure
2003
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women
2012
Calcium/Vitamin D Supplementation and Cardiovascular Events
2007
Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis
2014
Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys
2001
Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
2011
Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial
2000
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
2001
Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population
2009
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
2012
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
1983 Standout
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease
2008
Telomere length is paternally inherited and is associated with parental lifespan
2007 StandoutNobel
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 Standout
Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
1992
Adverse Metabolic Effect of Omega-3 Fatty Acids in Non-Insulin-Dependent Diabetes Mellitus
1988
Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
2012 Standout
Cancellous bone remodeling in type i (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
1990
Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.
1994
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism
2011
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
2010
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Oscillation and Chaos in Physiological Control Systems
1977 StandoutScience
Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study
2009
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
2010
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
1996
Effect of composition on glass-forming regions of iron-base alloy powders prepared by water atomization
1987
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
2008
Anabolic and Catabolic Regimens of Human Parathyroid Hormone 1–34 Elicit Bone- and Envelope-Specific Attenuation of Skeletal Effects in Sost-Deficient Mice
2011
Prediction of Incident Hip Fracture with the Estimated Femoral Strength by Finite Element Analysis of DXA Scans in the Study of Osteoporotic Fractures
2014
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Sclerostin: A gem from the genome leads to bone-building antibodies
2010
Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density.
1986
Strontium and paleodietary research: A review
1982
Cellular and molecular mechanisms of osteoporosis
1998
Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of Its Resorptive Action: Differential Effects of Intermittent and Continuous Administration*
1982
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
2010
Osteoporosis in Men
2008
Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
2011
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery.
1990
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
2011
The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1–34) on Bone Histomorphometry and Serum Chemistry in Rats*
1997
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
2007
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
New Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis
1999
Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation
2001
Appendicular Bone Density and Age Predict Hip Fracture in Women
1990
Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography
2008
Assessment of sex‐specific genetic and environmental effects on bone mineral density
2004
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis
1993
Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics
1986
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
1995
Fish oil inhibits development of atherosclerosis in rhesus monkeys.
1987
Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil
1986
Effects of Ethnicity and Age or Menopause on Osteoblast Function, Bone Mineralization, and Osteoid Accumulation in Iliac Bone
1997
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
2009
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
Dual‐photon bone densitometry in normal Australian women: a cross‐sectional study
1987
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
2001
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Risk Factors for Falls as a Cause of Hip Fracture in Women
1991
Risk Factors for Hip Fracture in White Women
1995 Standout
Stable Nitrogen Isotope Ratios of Bone Collagen Reflect Marine and Terrestrial Components of Prehistoric Human Diet
1983 StandoutScience
BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long-Term Results From the Study of Osteoporotic Fractures
2003
BIOMECHANICAL AND MOLECULAR REGULATION OF BONE REMODELING
2006
Lower Mortality From Coronary Heart Disease and Stroke at Higher Altitudes in Switzerland
2009
The amazing osteocyte
2010 Standout
Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters
2005
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
2016
Harnessing Nonlinearity: Predicting Chaotic Systems and Saving Energy in Wireless Communication
2004 StandoutScience
Deranged Mineral Content in the Bone of Patients with Chronic Renal Failure, Estimated by Computed Tomography
1985
Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP-Stimulated Bone Formation
2006
Histomorphometric profile and vitamin d status in patients with femoral neck fracture
1982
FEA to Measure Bone Strength: A Review
2016
Works of J. Reeve being referenced
Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
1984
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
1980
Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.
1976
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
1990
Combination of Nanoindentation and Quantitative Backscattered Electron Imaging Revealed Altered Bone Material Properties Associated with Femoral Neck Fragility
2009
Population-based geographic variations in dxa bone density in Europe: The evos study
1997
Relation between age, femoral neck cortical stability, and hip fracture risk
2005
Osteocyte density in aging subjects is enhanced in bone adjacent to remodeling haversian systems
2002
Future prospects for hormone replacement therapy
1992
A meta-analysis of previous fracture and subsequent fracture risk
2004
More acidic dietary acid-base load is associated with reduced calcaneal broadband ultrasound attenuation in women but not in men: results from the EPIC-Norfolk cohort study
2007
Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry
2002
Super‐osteons (remodeling clusters) in the cortex of the femoral shaft: Influence of age and gender
2001
Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)
1999
A novel mechanism for induction of increased cortical porosity in cases of intracapsular hip fracture
2000
Intracapsular Hip Fracture: Increased Cortical Remodeling in the Thinned and Porous Anterior Region of the Femoral Neck
1999
Body mass index as a predictor of fracture risk: A meta-analysis
2005
Regional differences in cortical porosity in the fractured femoral neck
1999
Skeletal Blood Flow, Iliac Histomorphometry, and Strontium Kinetics in Osteoporosis: A Relationship Between Blood Flow and Corrected Apposition Rate
1988
Improving Risk Assessment: Hip Geometry, Bone Mineral Distribution and Bone Strength in Hip Fracture Cases and Controls. The EPOS Study
2002
Rapid periarticular bone loss in rheumatoid arthritis
1990
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
1998
Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China?
2004
A family history of fracture and fracture risk: a meta-analysis
2004
Effects of gender, anthropometric variables, and aging on the evolution of hip strength in men and women aged over 65
2003
The relationship between serum vitamin D concentrations andin vivo tetracycline labeling of osteoid in crush fracture osteoporosis
1991
hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses
1991
Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone
1992
Falls explain between-center differences in the incidence of limb fracture across Europe
2002
Osteocyte function, osteocyte death and bone fracture resistance
2000
Parathyroid hormone — a bone anabolic and catabolic agent
2005
Quality of life as outcome in the treatment of osteoporosis: The development of a questionnaire for quality of life by the European foundation for osteoporosis
1997
Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS)
2003
Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDP
1988
The use of multiple sites for the diagnosis of osteoporosis
2006
Identification of apoptotic changes in osteocytes in normal and pathological human bone
1997
Gastrointestinal calcium absorption and dietary calcium load: Relationships with bone remodelling in vertebral osteoporosis
1995
Distribution of cortical bone in the femoral neck and hip fracture: A prospective case-control analysis of 143 incident hip fractures; the AGES-REYKJAVIK Study
2011
Hip section modulus, a measure of bending resistance, is more strongly related to reported physical activity than BMD
2003
Evidence for bone formation on the external "periosteal" surface of the femoral neck: a comparison of intracapsular hip fracture cases and controls
2003
Osteoclastic cortical erosion as a determinant of subperiosteal osteoblastic bone formation in the femoral neck’s response to BMU imbalance. Effects of stance-related loading and hip fracture
2004
A meta-analysis of milk intake and fracture risk: low utility for case finding
2004
Effects of physical activity on evolution of proximal femur structure in a younger elderly population
2006
Human parathyroid peptide treatment of vertebral osteoporosis
1993
Geographic and other determinants of BMD change in European men and women at the hip and spine. A population-based study from the Network in Europe for Male Osteoporosis (NEMO)
2006
Low bone mineral content is common but osteoporotic fractures are rare in elderly rural Gambian women
1996
The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
1981
Rates of New Bone Formation in Patients with Crush Fracture Osteoporosis
1982
A model-independent comparison of the rates of uptake and short term retention of47Ca and85Sr by the skeleton
1977
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone*
1997
BONE DENSITY MEASUREMENT WITH COMPUTED TOMOGRAPHY
1980
Bone turnover and trabecular plate survival after artificial menopause
1988
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
1991
Structure of the Femoral Neck in Hip Fracture: Cortical Bone Loss in the Inferoanterior to Superoposterior Axis
1999
Fall frequency and incidence of distal forearm fracture in the UK.
1995
When Should the Doctor Order a Spine X-Ray? Identifying Vertebral Fractures for Osteoporosis Care: Results From the European Prospective Osteoporosis Study (EPOS)
2004
Prediction of Incident Hip Fracture Risk by Femur Geometry Variables Measured by Hip Structural Analysis in the Study of Osteoporotic Fractures
2008
Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study
1997
Effects of Two Treatment Regimes with Synthetic Human Parathyroid Hormone Fragment on Bone Formation and the Tissue Balance of Trabecular Bone in Greyhounds
1983
Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies.
1985
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
2005 Standout
Intestinal Absorption of Calcium in Greyhounds: The Response to Intermittent and Continuous Administration of Human Synthetic Parathyroid Hormone Fragment 1–34 (Hpth 1–34)
1984
Smoking and fracture risk: a meta-analysis
2004
Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes.
1985
Bone turnover and trabecular plate survival after artificial menopause
1988
Pharmacokinetics of Synthetic Human Parathyroid Hormone 1-34 in man Measured by Cytochemical Bioassay and Radioimmunoassay
1985
Bone Remodeling at the Endocortical Surface of the Human Femoral Neck: A Mechanism for Regional Cortical Thinning in Cases of Hip Fracture
2003
Bone turnover and trabecular plate survival after artificial menopause.
1987
A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders
1977
Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: The influence of human parathyroid fragment (hPTH 1-34) therapy
1981
The Role of Estrogen in the Control of Rat Osteocyte Apoptosis
1998
A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk
2004
Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone
2003
Age and sex influences on fall characteristics.
1994
Predictive Value of BMD for Hip and Other Fractures
2005
Skeletal blood flow in paget's disease of bone
1981
Fractured Neck of Femur in the Elderly: An Attempt to Identify Patients at Risk
1979
A new method for calculating the accretion rate of bone calcium and some observations on the suitability of strontium-85 as a tracer for bone calcium
1976
Risedronate Slows or Partly Reverses Cortical and Trabecular Microarchitectural Deterioration in Postmenopausal Women
2013
Effect of Fe-B-Si composition on maximum thickness for casting amorphous metals
1982
An Analogue Model of Granulopoiesis for the Analysis of Isotopic and Other Data Obtained in the Non‐steady State
1973
PTH: A future role in the management of osteoporosis?
1996
Femoral Neck Trabecular Bone: Loss With Aging and Role in Preventing Fracture
2009
Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
1985
Periodic courses of human 1–34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis
1987
Changing structure of the femoral neck across the adult female lifespan
2009
Methods for the histological study of femoral neck bone remodelling in patients with fractured neck of femur
1993
Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids.
1993
Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture
2010
Measurement of lumbar spine bone mineral: a comparison of dual photon absorptiometry and computed tomography
1985
Reduced Vitamin D in Acute Stroke
2005
ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS
1976
Falls, Fractures, and Osteoporosis After Stroke
2002
Intracapsular Hip Fracture and the Region-Specific Loss of Cortical Bone: Analysis by Peripheral Quantitative Computed Tomography
2001
Validity of Self-Report of Fractures: Results from a Prospective Study in Men and Women Across Europe
2000